Altanserin
- Level
- Commodity
- Parent
- 51294500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51294502This classification denotes a serotonin antagonist with the molecular formula C22H22FN3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 5015H744JQ chemically known as 3-(2-(4-(p-fluorobenzoyl)piperidino)ethyl)-2-thio-2,4(1h,3h)-quinazolinedione but generally known as altanserin, which bears US NIH Compound Identifier 3033677. European Medicines Agency schedules Altanserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05375MIG. The term ALTANSERIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24. ). Most nations schedule altanserin under HS 29335995 and SITC 51576. As of Q4 2014, ALTANSERIN remains the US FDA Preferred Term for this commodity. Altanserin bears US NLM identifiers UMLS ID C0102811 and NCI Concept Code C77258. SMILES: C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=S.
Same parent
Under 51294500 · 23Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.